4.69
0.12 (2.63%)
| Penutupan Terdahulu | 4.57 |
| Buka | 4.59 |
| Jumlah Dagangan | 689,000 |
| Purata Dagangan (3B) | 7,018,853 |
| Modal Pasaran | 8,462,822,912 |
| Harga / Jualan (P/S) | 10.11 |
| Harga / Buku (P/B) | 10.02 |
| Julat 52 Minggu |
| Margin Keuntungan | -111.85% |
| Margin Operasi (TTM) | -90.38% |
| EPS Cair (TTM) | -0.260 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 226.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 124.69% |
| Nisbah Semasa (MRQ) | 0.620 |
| Aliran Tunai Operasi (OCF TTM) | -196.39 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -185.08 M |
| Pulangan Atas Aset (ROA TTM) | -10.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -54.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | LEPU BIO-B | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.25 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| LEPU BIO-B | 8 B | - | - | 10.02 |
| GENSCRIPT BIO | 25 B | - | - | 0.720 |
| CARSGEN-B | 8 B | - | - | 6.98 |
| OCUMENSION-B | 6 B | - | - | 1.32 |
| JACOBIO-B | 5 B | - | - | 5.53 |
| BIODLINK-B | 3 B | - | 211.50 | 3.52 |
|
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in Mainland China. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain. The company generates the majority of its revenue from the Sale of pharmaceutical products. The company also generates a small portion of its revenue from Licensing income. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 62.64% |
| % Dimiliki oleh Institusi | 5.59% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |